WO2000047549A1 - Preparation of iodixanol - Google Patents
Preparation of iodixanol Download PDFInfo
- Publication number
- WO2000047549A1 WO2000047549A1 PCT/GB2000/000413 GB0000413W WO0047549A1 WO 2000047549 A1 WO2000047549 A1 WO 2000047549A1 GB 0000413 W GB0000413 W GB 0000413W WO 0047549 A1 WO0047549 A1 WO 0047549A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- iodixanol
- dimerisation
- process according
- recovered
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
Definitions
- This invention is concerned with the synthesis of iodixanol .
- Iodixanol (1 , 3 -bis (acetamido) -N,N'-bis[3,5-bis(2,3- dihydroxypropylaminocarbonyl) -2,4, 6-triiodophenyl] -2- hydroxypropane) is a non-ionic X-ray contrast agent which is currently manufactured in large quantities. A number of methods are known for its preparation but these are all multistep processes and the cost of the final formulated product thus mainly depends on these processes. It is therefore important to optimise these processes for both economic and environmental reasons.
- Priebe et.al. (Acta Radiol . 36 (1995), Suppl . 399, 21- 31) describe another route which avoids the difficult last step of the above process.
- the route involves eight reaction steps from 5-nitro ⁇ sophthalic acid, which is undesirable, and one of the steps includes chlorination with thionyl chloride, which is extremely corrosive.
- the introduction of the iodine atoms takes place very early in the sequence, which is disadvantageous as iodine is the most expensive reagent in the process .
- the yield and final purification method for this route have not been reported.
- the third route to iodixanol involves the synthesis of 5-amino-2, 4, 6-triiodoisophthalic acid (WO 96/37458) and then its dichloride (WO 96/37459) , followed by conversion into Compound A (US 5705692) and finally dimerisation as in the first process above.
- This method thus has the same disadvantages as the first, and also uses an undesirable acid chlorination step.
- the invention thus provides a process for the preparation of iodixanol by dimerisation of Compound A in which, after the dimerisation step, unreacted Compound A is precipitated from the reaction mixture and recovered for re-use.
- the dimerisation step itself may be carried out as described in NO 161368 and WO 98/23296, for example using epichlorohydrin, 1 , 3-dichloro-2-hydroxypropane or 1 , 3-dibromo-2 -hydroxypropane as the dimerisation agent.
- the reaction is usually carried out in a non-aqueous solvent such as a ⁇ . 6 alcohol, preferably 2- methoxyethanol or methanol, and generally results in the conversion of 40-60% of Compound A to iodixanol. Dimerisation in pure water or mixtures of water and one or more alcohols (e.g. Cj.g-alkanols) is also possible.
- Precipitation of Compound A from a non-aqueous reaction mixture can be effected after addition of water, for example in an amount of 1-2, preferably 1.3-1.8 L/kg Compound A used as starting material. If water is present in the reaction mixture, the amount of water added for precipitation can be reduced accordingly.
- An alcoholic co-solvent e.g. a C _ 6 alkanol such as methanol
- alkali e.g. sodium hydroxide.
- the pH of the solution is then adjusted to about 10-11 by addition of an acid, e.g. hydrochloric acid, to provoke precipitation of unreacted Compound A and if necessary the temperature can be adjusted to 15-40°C, preferably 18-30°C.
- the solution is optionally seeded with crystals of Compound A to initiate the precipitation of Compound A, while the iodixanol formed stays in solution.
- the separated Compound A from the recovery process can optionally be recrystallised, for example from water/ ethanol or another alkanol .
- the moist material from the filtration/centrifugation may be dissolved in water in the presence of alkali.
- the amount of water should be about 2-7 l/kg of Compound A, preferably 3-5 l/kg.
- Alkali e.g. aqueous sodium hydroxide, should be added until all traces of undissolved material are removed.
- the solution may optionally be filtered to remove remaining traces of undissolved matter.
- An alcohol e.g.
- methanol (0.5-1.5 l/kg of Compound A, preferably 0.5-1.0 litres/kg) may then be added, and the mixture heated to 40-80°C, preferably 50-60°C. Adjustment of pH by an acid, e.g. hydrochloric acid, causes pure Compound A to precipitate.
- the mixture may optionally be seeded with a small amount of Compound A crystals. Maximum yield from the recrystallisation is obtained if the pH is finally adjusted to about 5-7, e.g. with hydrochloric acid, followed by cooling to 10-25°C.
- the slurry may optionally be stirred at this temperature to enhance the crystallisation, e.g. 2-18 hours.
- the precipitate is separated from the suspension by any conventional technique, for instance centrifugation or filtration, and optionally washed with water, methanol or another suitable alkanol.
- the recovered Compound A may advantageously be dried, e.g. under reduced pressure, before reuse in a new dimerisation.
- Recovered Compound A, together if necessary with further fresh Compound A, may be used in a new dimerisation reaction as described above, followed by subsequent recovery of unreacted Compound A.
- the invention thus also includes process in which iodixanol is prepared in a series of successive processes according to the invention in which, after the dimerisation, unreacted Compound A is precipitated from the reaction mixture and recovered, optionally crystallised, and then re-used in a subsequent process in the series.
- the dimerisation reactions in such a series will normally be substantially identical, and the unreacted Compound A will normally be recovered after each dimerisation step.
- the pH was adjusted to 10.8 by 18% hydrochloric acid, and the solution seeded with 1 g of Compound A.
- the pH of the resulting suspension was further pH-adjusted with 18% hydrochloric acid to pH 4.0.
- the suspension was left with stirring overnight before filtration and washing with water (60 ml) on the filter.
- the filtrate was further desalinated and crystallised by conventional methods, providing iodixanol suitable for pharmaceutical use.
- the material on the filter was analysed on HPLC, showing 94.3% Compound A and 5.1% iodixanol.
- the recovered Compound A from Example 1 was taken directly from the filter without drying, and completely dissolved in water (440 ml) and 50% aqueous NaOH (15 ml) . The solution was filtered through a 3 ⁇ m filter to remove traces of insoluble matter, and some more water
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compounds Of Unknown Constitution (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Abstract
Description
Claims
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00902754A EP1150943B1 (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
IL14396900A IL143969A0 (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
AU24495/00A AU2449500A (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
HU0105096A HU228226B1 (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
CA002356942A CA2356942C (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
AT00902754T ATE249420T1 (en) | 1999-02-11 | 2000-02-10 | PRODUCTION OF IODIXANOL |
PL348857A PL197893B1 (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
DE60005143T DE60005143T2 (en) | 1999-02-11 | 2000-02-10 | PRODUCTION OF IODIXANOL |
JP2000598470A JP4545945B2 (en) | 1999-02-11 | 2000-02-10 | Production of iodixanol |
US09/923,074 US6974882B2 (en) | 1999-02-11 | 2001-08-06 | Preparation of iodixanol |
NO20013881A NO329363B1 (en) | 1999-02-11 | 2001-08-09 | Process for Preparation of Iodixanol |
US11/288,029 US20060137602A1 (en) | 1999-02-11 | 2005-11-28 | Preparation of iodixanol |
US11/680,716 US20070203362A1 (en) | 1999-02-11 | 2007-03-01 | Preparation of iodixanol |
US11/958,714 US20080161606A1 (en) | 1999-02-11 | 2007-12-18 | Preparation of iodixanol |
US12/245,886 US20090112022A1 (en) | 1999-02-11 | 2008-10-06 | Preparation of iodixanol |
US12/545,884 US20100069669A1 (en) | 1999-02-11 | 2009-08-24 | Preparation of Iodixanol |
US12/862,023 US20110207963A1 (en) | 1999-02-11 | 2010-08-24 | Preparation of iodixanol |
US13/267,133 US20120083625A1 (en) | 1999-02-11 | 2011-10-06 | Preparation of iodixanol |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9903109.8A GB9903109D0 (en) | 1999-02-11 | 1999-02-11 | Process |
GB9903109.8 | 1999-02-11 | ||
US12153999P | 1999-02-25 | 1999-02-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/923,074 Continuation US6974882B2 (en) | 1999-02-11 | 2001-08-06 | Preparation of iodixanol |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000047549A1 true WO2000047549A1 (en) | 2000-08-17 |
Family
ID=10847565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/000413 WO2000047549A1 (en) | 1999-02-11 | 2000-02-10 | Preparation of iodixanol |
Country Status (18)
Country | Link |
---|---|
US (8) | US6974882B2 (en) |
EP (1) | EP1150943B1 (en) |
JP (1) | JP4545945B2 (en) |
KR (1) | KR100625139B1 (en) |
CN (1) | CN1178899C (en) |
AT (1) | ATE249420T1 (en) |
AU (1) | AU2449500A (en) |
CA (1) | CA2356942C (en) |
CZ (1) | CZ296353B6 (en) |
DE (1) | DE60005143T2 (en) |
ES (1) | ES2206190T3 (en) |
GB (1) | GB9903109D0 (en) |
HU (1) | HU228226B1 (en) |
IL (1) | IL143969A0 (en) |
NO (1) | NO329363B1 (en) |
PL (1) | PL197893B1 (en) |
PT (1) | PT1150943E (en) |
WO (1) | WO2000047549A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100574087B1 (en) | 2004-09-09 | 2006-04-27 | 주식회사태준제약 | Process for the preparing Iodixanol as X-ray contrast media |
WO2007073202A1 (en) | 2005-12-19 | 2007-06-28 | Ge Healthcare As | Purification process of iodixanol |
US7696381B1 (en) | 2009-07-21 | 2010-04-13 | Ge Healthcare As | Alternative dimerisation reagents for synthesis of iodixanol |
EP2277856A1 (en) | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Crystallization of iodixanol using ultrasound |
EP2277855A1 (en) | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Crystallization of iodixanol using milling |
WO2011063551A1 (en) | 2009-11-26 | 2011-06-03 | Hovione China Holding Limited | Preparation and purification of iodixanol |
WO2014052091A1 (en) * | 2012-09-27 | 2014-04-03 | Ge Healthcare As | Preparation of an intermediate compound of ioforminol |
US9738596B2 (en) | 2007-07-12 | 2017-08-22 | Ge Healthcare As | Contrast agents |
US11878137B2 (en) | 2006-10-18 | 2024-01-23 | Medical Components, Inc. | Venous access port assembly with X-ray discernable indicia |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100700701B1 (en) * | 2004-10-28 | 2007-03-28 | 동국정밀화학(주) | Preparation method of iodixanol |
NO20053687D0 (en) * | 2005-07-29 | 2005-07-29 | Amersham Health As | Crystallization Process. |
NO20055702D0 (en) * | 2005-12-02 | 2005-12-02 | Amersham Health As | Contrast agents |
US20070148096A1 (en) * | 2005-12-15 | 2007-06-28 | Lars-Goran Wistrand | Contrast Agents |
CN101195587B (en) * | 2006-12-19 | 2010-07-21 | 浙江尖峰海洲制药有限公司 | Production method for lodixanol hydrolysate |
CN101293855B (en) * | 2007-04-27 | 2012-08-29 | 上海冠杰生物医药科技有限公司 | Purification process for Iodixanol |
US20110021822A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | continuous deacetylation and purification process in synthesis of non-ionic x-ray contrast agents |
US20110021828A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Recovering unreacted intermediate from desalinated and desolventized dimerisation reaction mixture by ultrafiltration |
US20110021825A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Process for isolating iodixanol from an aqueous solution |
US20110021833A1 (en) | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Crystallization of an intermediate for synthesizing non-ionic x-ray contrast agents |
US8962886B2 (en) * | 2009-07-21 | 2015-02-24 | Ge Healthcare As | Synthesis of iodixanol in methanol |
US20110021832A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Synthesis of iodixanol in water |
US8969619B2 (en) * | 2009-07-21 | 2015-03-03 | Ge Healthcare As | Synthesis of iodixanol in propyleneglycol |
US20110021821A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Continuous acetylation process in synthesis of non-ionic x-ray contrast agents |
US20110020238A1 (en) | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Stabilizing aqueous solution of iodine chloride by adding sodium chloride |
US20110021823A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Processing crude iodixanol mixture by nanofiltration |
US8962887B2 (en) * | 2009-07-21 | 2015-02-24 | Ge Healthcare As | Synthesis of iodixanol in 1-methoxy-2-propanol and water or methanol |
US7754920B1 (en) * | 2009-07-21 | 2010-07-13 | Ge Healthcare As | Solvent reduction in crystallisation of intermediate for non-ionic X-ray contrast agents |
US8461600B2 (en) * | 2009-09-11 | 2013-06-11 | Ut-Battelle, Llc | Method for morphological control and encapsulation of materials for electronics and energy applications |
CN102079716B (en) * | 2009-11-26 | 2014-03-05 | 浙江台州海神制药有限公司 | Preparation and purification of iodixanol |
ES2680019T3 (en) | 2010-12-21 | 2018-09-03 | Ge Healthcare As | Desalination of a composition comprising a contrast agent |
CN103058880B (en) * | 2011-10-21 | 2015-08-05 | 连云港润众制药有限公司 | The preparation method of Visipaque 320 and synthetic intermediate thereof |
CN102875411A (en) * | 2012-10-30 | 2013-01-16 | 广州牌牌生物科技有限公司 | Method for separating and purifying iodixanol injection raw materials by macroporous resin |
PT2917174T (en) * | 2012-11-12 | 2018-11-14 | Ge Healthcare As | Preparation of intermediates of x-ray contrast agents |
CN103265449A (en) * | 2013-05-30 | 2013-08-28 | 四川铂瑞生物医药有限公司 | Synthesis of 5-amino-2,4,6-triiodo-N, N'-bis(2,3-dihydroxy propyl)-1,3-benzenedicarboxamide |
CN105873898B (en) | 2013-12-06 | 2019-06-25 | 通用电气医疗集团股份有限公司 | Purify the alternatives of the intermediate in the synthesis of nonionic X-ray contrast agent |
CN113831256B (en) * | 2021-09-17 | 2024-06-11 | 江苏宇田医药有限公司 | Intermediate of iodixanol and method for preparing iodixanol |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0108638A1 (en) * | 1982-11-08 | 1984-05-16 | NYEGAARD & CO. A/S | X-ray contrast agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3816521A (en) * | 1967-10-02 | 1974-06-11 | Ueno Pharm Co Ltd | Process for the production of p-hydroxy benzoic acid |
US5235116A (en) * | 1992-08-24 | 1993-08-10 | Eastman Kodak Company | Process for the preparation of 2-(1-phenylethyl)hydroquinone and 2-(1-phenylethyl)hydroquinone diacetate |
GB9618055D0 (en) | 1996-08-29 | 1996-10-09 | Nycomed Imaging As | Process |
GB9624612D0 (en) * | 1996-11-26 | 1997-01-15 | Nycomed Imaging As | Process |
-
1999
- 1999-02-11 GB GBGB9903109.8A patent/GB9903109D0/en not_active Ceased
-
2000
- 2000-02-10 EP EP00902754A patent/EP1150943B1/en not_active Expired - Lifetime
- 2000-02-10 CN CNB008037051A patent/CN1178899C/en not_active Expired - Lifetime
- 2000-02-10 PL PL348857A patent/PL197893B1/en unknown
- 2000-02-10 AT AT00902754T patent/ATE249420T1/en not_active IP Right Cessation
- 2000-02-10 WO PCT/GB2000/000413 patent/WO2000047549A1/en active IP Right Grant
- 2000-02-10 KR KR1020017010055A patent/KR100625139B1/en active IP Right Grant
- 2000-02-10 AU AU24495/00A patent/AU2449500A/en not_active Abandoned
- 2000-02-10 JP JP2000598470A patent/JP4545945B2/en not_active Expired - Lifetime
- 2000-02-10 IL IL14396900A patent/IL143969A0/en not_active IP Right Cessation
- 2000-02-10 DE DE60005143T patent/DE60005143T2/en not_active Expired - Lifetime
- 2000-02-10 CZ CZ20012891A patent/CZ296353B6/en not_active IP Right Cessation
- 2000-02-10 PT PT00902754T patent/PT1150943E/en unknown
- 2000-02-10 HU HU0105096A patent/HU228226B1/en unknown
- 2000-02-10 CA CA002356942A patent/CA2356942C/en not_active Expired - Lifetime
- 2000-02-10 ES ES00902754T patent/ES2206190T3/en not_active Expired - Lifetime
-
2001
- 2001-08-06 US US09/923,074 patent/US6974882B2/en not_active Expired - Lifetime
- 2001-08-09 NO NO20013881A patent/NO329363B1/en not_active IP Right Cessation
-
2005
- 2005-11-28 US US11/288,029 patent/US20060137602A1/en not_active Abandoned
-
2007
- 2007-03-01 US US11/680,716 patent/US20070203362A1/en not_active Abandoned
- 2007-12-18 US US11/958,714 patent/US20080161606A1/en not_active Abandoned
-
2008
- 2008-10-06 US US12/245,886 patent/US20090112022A1/en not_active Abandoned
-
2009
- 2009-08-24 US US12/545,884 patent/US20100069669A1/en not_active Abandoned
-
2010
- 2010-08-24 US US12/862,023 patent/US20110207963A1/en not_active Abandoned
-
2011
- 2011-10-06 US US13/267,133 patent/US20120083625A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0108638A1 (en) * | 1982-11-08 | 1984-05-16 | NYEGAARD & CO. A/S | X-ray contrast agents |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100574087B1 (en) | 2004-09-09 | 2006-04-27 | 주식회사태준제약 | Process for the preparing Iodixanol as X-ray contrast media |
WO2007073202A1 (en) | 2005-12-19 | 2007-06-28 | Ge Healthcare As | Purification process of iodixanol |
US11878137B2 (en) | 2006-10-18 | 2024-01-23 | Medical Components, Inc. | Venous access port assembly with X-ray discernable indicia |
US9738596B2 (en) | 2007-07-12 | 2017-08-22 | Ge Healthcare As | Contrast agents |
EP2277855A1 (en) | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Crystallization of iodixanol using milling |
EP2277856A1 (en) | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Crystallization of iodixanol using ultrasound |
EP2281802A1 (en) * | 2009-07-21 | 2011-02-09 | GE Healthcare AS | Alternative dimerisation reagents for synthesis of iodixanol |
US7696381B1 (en) | 2009-07-21 | 2010-04-13 | Ge Healthcare As | Alternative dimerisation reagents for synthesis of iodixanol |
WO2011063551A1 (en) | 2009-11-26 | 2011-06-03 | Hovione China Holding Limited | Preparation and purification of iodixanol |
AU2009355814A1 (en) * | 2009-11-26 | 2012-06-07 | Imax Diagnostic Imaging Holding Ltd | Preparation and purification of iodixanol |
US8766002B2 (en) | 2009-11-26 | 2014-07-01 | Imax Diagnostic Imaging Holding Limited | Preparation and purification of iodixanol |
AU2009355814B2 (en) * | 2009-11-26 | 2016-06-30 | Imax Diagnostic Imaging Holding Ltd | Preparation and purification of iodixanol |
WO2014052091A1 (en) * | 2012-09-27 | 2014-04-03 | Ge Healthcare As | Preparation of an intermediate compound of ioforminol |
AU2013323981B2 (en) * | 2012-09-27 | 2017-09-14 | Ge Healthcare As | Preparation of an intermediate compound of Ioforminol |
US9884808B2 (en) | 2012-09-27 | 2018-02-06 | Ge Healthcare As | Preparation of an intermediate compound of ioforminol |
RU2654461C2 (en) * | 2012-09-27 | 2018-05-18 | ДжиИ Хелткер АС | Preparation of an intermediate compound of ioforminol synthesis |
CN110003038A (en) * | 2012-09-27 | 2019-07-12 | 通用电气医疗集团股份有限公司 | The preparation of the midbody compound of Ioforminol |
CN104661996A (en) * | 2012-09-27 | 2015-05-27 | 通用电气医疗集团股份有限公司 | Preparation of an intermediate compound of ioforminol |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1150943B1 (en) | Preparation of iodixanol | |
RU2385316C2 (en) | Iodixanol synthesis | |
EP1960349B1 (en) | Purification of iodixanol | |
EP1966110B1 (en) | Purification process of iodixanol | |
KR20110009039A (en) | A continuous deacetylation and purification process in synthesis of non-ionic x-ray contrast agents | |
AU723184B2 (en) | Process for iohexol manufacture | |
JP2002531432A (en) | Method for preparing N, N'-bis [2,3-dihydroxypropyl] -5-[(hydroxyacetyl) methylamino] -2,4,6-triiodo-1,3-benzenedicarboxamide | |
JPH08333319A (en) | Purifying and crystallizing method for iopamidol | |
JP3521242B2 (en) | Purification method of biscresols | |
CA2710577C (en) | Crystallization of iodixanol using milling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00803705.1 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 143969 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2356942 Country of ref document: CA Ref document number: 2356942 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000902754 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2001/00921/MU Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09923074 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-2891 Country of ref document: CZ Ref document number: 1020017010055 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2000 598470 Country of ref document: JP Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2000902754 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017010055 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-2891 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000902754 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: PV2001-2891 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020017010055 Country of ref document: KR |